Earth Life Scien Financials

CLTS

Source SEC Filings (10-K/10-Q) Data as of Sep 30, 2022 Currency USD FYE December

This page shows Earth Life Scien (CLTS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score pending refresh

We are recalculating Earth Life Scien's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Earnings Quality Low Quality

0.01x

For every $1 of reported earnings, Earth Life Scien generates $0.01 in operating cash flow (-$16K OCF vs -$1.6M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

-$1.6M

Earth Life Scien reported -$1.6M in net income in fiscal year 2021.

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

961M

YoY+106.7%

5Y CAGR+28.8%

Earth Life Scien had 961M shares outstanding in fiscal year 2021. This represents an increase of 106.7% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

-39.1%

5Y CAGR-37.2pp

Earth Life Scien's ROE was -39.1% in fiscal year 2021, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

CLTS Income Statement

Metric	FY21	FY20	FY19	FY18	FY17	FY16
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$23K-28.2%	$33K+214.1%	$10K	N/A	N/A	$22K
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$22K	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$1.6M	N/A	-$54K	N/A	N/A	-$122K
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21	Q2'21	Q1'21	Q4'20
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$11K+819.8%	$1K-45.5%	$2K	N/A	$9K+193.7%	$3K+3.0%	$3K	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$2K-49.0%	$5K-10.0%	$5K	N/A	$6K+1.3%	$6K+11.7%	$5K	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$21K+93.5%	-$322K-799.5%	-$36K	N/A	-$22K-103.8%	-$11K	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CLTS Balance Sheet

Metric	FY21	FY20	FY19	FY18	FY17	FY16
Total Assets	$4.4M+2415.1%	$176K	$0-100.0%	$490-50.0%	$980-100.0%	$6.8M
Current Assets	N/A	$176K	N/A	N/A	N/A	N/A
Cash & Equivalents	N/A	N/A	N/A	N/A	N/A	N/A
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$373K-1.3%	$378K+11.9%	$338K+18.7%	$284K-6.1%	$303K+12.0%	$271K
Current Liabilities	N/A	$378K+11.9%	$338K+18.7%	$284K-7.9%	$309K+14.2%	$271K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$4.1M+2107.7%	-$202K+40.2%	-$338K-18.9%	-$284K+5.9%	-$302K-104.7%	$6.5M
Retained Earnings	-$18.7M-9.3%	-$17.1M-12.0%	-$15.3M-0.4%	-$15.2M-3.0%	-$14.8M-84.7%	-$8.0M

Metric	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21	Q2'21	Q1'21	Q4'20
Total Assets	$4.4M0.0%	$4.4M0.0%	$4.4M0.0%	$4.4M+2400.9%	$177K-1.7%	$180K0.0%	$180K+2.3%	$176K
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	$4K-97.7%	$176K
Cash & Equivalents	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$411K+5.4%	$390K-4.6%	$409K+9.6%	$373K-0.5%	$375K+5.5%	$355K+3.2%	$344K-8.9%	$378K
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	$344K-8.9%	$378K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$4.0M-0.5%	$4.0M+0.5%	$4.0M-0.9%	$4.1M+2150.4%	-$198K-12.8%	-$175K-6.7%	-$164K+18.6%	-$202K
Retained Earnings	-$19.1M-0.1%	-$19.1M-1.7%	-$18.7M-0.2%	-$18.7M-0.1%	-$18.7M-0.1%	-$18.7M-0.1%	-$18.7M-9.0%	-$17.1M

CLTS Cash Flow Statement

Metric	FY21	FY20	FY19	FY18	FY17	FY16
Operating Cash Flow	-$16K+65.0%	-$45K-32.2%	-$34K	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$16K-65.0%	$45K+32.2%	$34K	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21	Q2'21	Q1'21	Q4'20
Operating Cash Flow	$0+100.0%	-$4K-404.1%	-$800-126.6%	$3K	$0+100.0%	-$6K+53.4%	-$13K+37.7%	-$21K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$0-100.0%	$4K+404.1%	$800	$0+100.0%	-$3K-150.0%	$6K-53.4%	$13K-37.7%	$21K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CLTS Financial Ratios

Metric	FY21	FY20	FY19	FY18	FY17	FY16
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-39.1%	N/A	N/A	N/A	N/A	-1.9%
Return on Assets	-35.8%	N/A	N/A	N/A	N/A	-1.8%
Current Ratio	N/A	0.47	N/A	N/A	N/A	N/A
Debt-to-Equity	0.09	N/A	N/A	N/A	N/A	0.04
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21	Q2'21	Q1'21	Q4'20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-0.5%+7.5pp	-8.0%-7.1pp	-0.9%	N/A	N/A	N/A	N/A	N/A
Return on Assets	-0.5%+6.8pp	-7.3%-6.5pp	-0.8%	N/A	-12.7%-6.5pp	-6.1%	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	0.01-0.5	0.47
Debt-to-Equity	0.100.0	0.100.0	0.100.0	0.09	N/A	N/A	N/A	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Appliqate APQT

$107K

Wee-Cig Internat WCIG

$67K

Resgreen Group RGGI

$49K

Dlt Resolution Inc DLTI

$66.9M

Yuenglings Ice YCRM

$290K

Frequently Asked Questions

Is Earth Life Scien profitable?

No, Earth Life Scien (CLTS) reported a net income of -$1.6M in fiscal year 2021.

What is Earth Life Scien's return on equity (ROE)?

Earth Life Scien (CLTS) has a return on equity of -39.1% for fiscal year 2021, measuring how efficiently the company generates profit from shareholder equity.

What is Earth Life Scien's operating cash flow?

Earth Life Scien (CLTS) generated -$16K in operating cash flow during fiscal year 2021, representing cash generated from core business activities.

What are Earth Life Scien's total assets?

Earth Life Scien (CLTS) had $4.4M in total assets as of fiscal year 2021, including both current and long-term assets.

How many shares does Earth Life Scien have outstanding?

Earth Life Scien (CLTS) had 961M shares outstanding as of fiscal year 2021.

What is Earth Life Scien's debt-to-equity ratio?

Earth Life Scien (CLTS) had a debt-to-equity ratio of 0.09 as of fiscal year 2021, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Earth Life Scien's return on assets (ROA)?

Earth Life Scien (CLTS) had a return on assets of -35.8% for fiscal year 2021, measuring how efficiently the company uses its assets to generate profit.

Are Earth Life Scien's earnings high quality?

Earth Life Scien (CLTS) has an earnings quality ratio of 0.01x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.